Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Non-Current Deffered Revenue (2016 - 2025)

Bio Key International's Non-Current Deffered Revenue history spans 15 years, with the latest figure at $75146.0 for Q3 2025.

  • For Q3 2025, Non-Current Deffered Revenue fell 68.78% year-over-year to $75146.0; the TTM value through Sep 2025 reached $75146.0, down 68.78%, while the annual FY2024 figure was $196237.0, 593.51% up from the prior year.
  • Non-Current Deffered Revenue for Q3 2025 was $75146.0 at Bio Key International, down from $96729.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $240664.0 in Q3 2024 and bottomed at $28296.0 in Q4 2023.
  • The 5-year median for Non-Current Deffered Revenue is $71037.0 (2021), against an average of $88054.9.
  • The largest annual shift saw Non-Current Deffered Revenue soared 643.85% in 2024 before it crashed 68.78% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $67300.0 in 2021, then decreased by 22.53% to $52134.0 in 2022, then plummeted by 45.72% to $28296.0 in 2023, then surged by 593.51% to $196237.0 in 2024, then plummeted by 61.71% to $75146.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Non-Current Deffered Revenue are $75146.0 (Q3 2025), $96729.0 (Q2 2025), and $136931.0 (Q1 2025).